FDA has awarded 6 additional National Priority Vouchers. The latest recipients tackle major health challenges: HER2 lung cancer, drug-resistant TB in children, rectal cancer, sickle cell disease, and obesity. When companies commit to accessibility and national priorities, we commit to speed.
fda.gov/news-events/press-an…